SNA 006
Alternative Names: 68Ga-NODAGA-SNA006; SNA-006Latest Information Update: 28 Dec 2024
Price :
$50 *
At a glance
- Originator Alphamab Oncology
- Developer SmartNuclide Biopharma
- Class Antibody diagnostics; Diagnostic agents; Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Diagnostic imaging enhancers; Positron-emission tomography enhancers; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 28 Dec 2024 No recent reports of development identified for phase-I development in Solid-tumours(Diagnosis) in China (IV, Injection)
- 29 Nov 2021 Pharmacodynamics data of preclinical studies released be SmartNuclide Biopharma
- 02 Nov 2021 Phase-I clinical trials in Solid tumours in China (IV) (NCT05126927)